Dr. Ivan Quintanar Smith, MD

Dr. Quintanar Smith practices at Baptist Health Medical Center-Little Rock in Little Rock, Arkansas, part of Baptist Health.

Dr. Quintanar Smith's NPI, 1235365800, was assigned on June 9, 2009. Dr. Quintanar Smith holds Arkansas license E6215.

Dr. Quintanar Smith's primary practice is Baptist Health Medical Center-Little Rock, at 9601 Baptist Health Drive, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 202-2000.

Dr. Quintanar Smith's primary practice is Baptist Health Medical Center-Little Rock in Little Rock, Arkansas, part of Baptist Health. Dr. Quintanar Smith is also affiliated with Baptist Health Medical Center-North Little Rock. The medical group on file is Arkansas Health Group. Dmand AI also links Dr. Quintanar Smith to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quintanar Smith practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Quintanar Smith's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Quintanar Smith is licensed in Arkansas.

CMS data shows 1,665 Medicare services from Dr. Quintanar Smith across 6 procedure codes in 2024, for 596 Medicare patients. Medicare paid $120,986 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 596 Medicare patients who saw Dr. Quintanar Smith in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quintanar Smith's median patient age at 70, with 56% women.

In 2024, Dr. Quintanar Smith wrote 503 Medicare Part D claims for 200 patients. 82% of them were for generic drugs. CMS names the drug for 269 of them, across 15 drugs with 11 or more claims each, at $20,570 in total drug cost. In 2023, CMS named 152 claims across 9 drugs.

Dr. Quintanar Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Dr. Quintanar Smith from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $409.